Skip to main content
. 2020 Jun 24;33(4):e00028-20. doi: 10.1128/CMR.00028-20

TABLE 1.

FDA-approved in vitro Emergency Use Authorization diagnostics available for SARS-CoV-2 as of 30 March 2020a

Developer Diagnostic platform
Centers for Disease Control and Prevention (CDC) CDC 2019-nCoV real-time RT-PCR diagnostic panel
Wadsworth Center, New York State Department of Public Health (CDC) New York SARS-CoV-2 real-time reverse transcriptase (RT)-PCR diagnostic panel
Roche Molecular Systems, Inc. (RMS) cobas SARS-CoV-2
Thermo Fisher Scientific, Inc. TaqPath COVID-19 combo kit
Laboratory Corporation of America (LabCorp) COVID-19 RT-PCR test
Hologic, Inc. Panther fusion SARS-CoV-2
Quest Diagnostics Infectious Disease, Inc. Quest SARS-CoV-2 rRT-PCR
Quidel Corporation Lyra SARS-CoV-2 assay
Abbott Molecular Abbott RealTime SARS-CoV-2 assay
GenMark Diagnostics, Inc. ePlex SARS-CoV-2 test
DiaSorin Molecular, LLC Simplexa COVID-19 direct assay
Cepheid Xpert Xpress SARS-CoV-2 test
Primerdesign, Ltd. COVID-19 Genesig real-time PCR assay
Mesa Biotech, Inc. Accula SARS-Cov-2 test
BioFire Defense, LLC BioFire COVID-19 test
PerkinElmer, Inc. PerkinElmer new coronavirus nucleic acid detection kit
Avellino Lab USA, Inc. AvellinoCoV2 test
BGI Genomics, Co. Ltd. Real-time fluorescent RT-PCR kit for detecting SARS-2019-nCoV
Luminex Molecular Diagnostics, Inc. NxTAG CoV extended panel assay
Abbott Diagnostics Scarborough, Inc. ID Now COVID-19
Qiagen GmbH QIAstat-Dx respiratory SARS-CoV-2 panel
NeuMoDx Molecular, Inc. NeuMoDx SARS-CoV-2 assay
a

Data are from references 258 and 259.